Revista de Oncologia Ortopédica

Abstrato

Clinical Outcomes of Grade 3 Giant Cell Tumor of Bone After Extended Intralesional Curettage

Sukpanichyingyong S and Sangkomkamhang T

Introduction: The recommended treatment of grade 3 giant cell tumor of bone (grade 3 GCTB) aims to eliminate tumor and conserve limb with extended intralesional curettage. This treatment makes patients better function of bone and joint as usual. Even it can reduce postoperative complications and replace endoprosthesis. Still, there is limited information about the outcomes of surgical treatment and recurrence of the disease. This study aimed to evaluate the clinical outcomes and recurrence of grade 3 GCTB with extended intralesional curettage. Case Description: This study performed a retrospective review of 26 consecutive patients with grade 3 GCTB treated by extended intralesional curettage at Khon Kaen hospital from June 2012 to May 2017. Clinical outcomes including, functional analysis according to Musculoskeletal Tumor Society functional classification (MSTS score), pain score, postoperative complication and recurrence rate were evaluated. Twenty out of twenty-six patients were motion as usual within 6 months after surgery while recurrence of the disease is shown only one case. However, postoperative complications have not yet been reported. Conclusion: The extended intralesional curettage of grade 3 GCTB grade is an effective treatment. Nevertheless, it have to keep recall the patient for detection of disease recurrence.